GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » EV-to-FCF

ClouDr Group (HKSE:09955) EV-to-FCF : -5.72 (As of May. 16, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ClouDr Group's Enterprise Value is HK$1,647 Mil. ClouDr Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-288 Mil. Therefore, ClouDr Group's EV-to-FCF for today is -5.72.

The historical rank and industry rank for ClouDr Group's EV-to-FCF or its related term are showing as below:

HKSE:09955' s EV-to-FCF Range Over the Past 10 Years
Min: -27.54   Med: -2.69   Max: -1.42
Current: -5.72

During the past 5 years, the highest EV-to-FCF of ClouDr Group was -1.42. The lowest was -27.54. And the median was -2.69.

HKSE:09955's EV-to-FCF is ranked worse than
100% of 62 companies
in the Medical Distribution industry
Industry Median: 20.635 vs HKSE:09955: -5.72

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), ClouDr Group's stock price is HK$3.31. ClouDr Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.656. Therefore, ClouDr Group's PE Ratio for today is At Loss.


ClouDr Group EV-to-FCF Historical Data

The historical data trend for ClouDr Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group EV-to-FCF Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - - -8.13 -12.48

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial - - -8.13 - -12.48

Competitive Comparison of ClouDr Group's EV-to-FCF

For the Medical Distribution subindustry, ClouDr Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClouDr Group's EV-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ClouDr Group's EV-to-FCF falls into.



ClouDr Group EV-to-FCF Calculation

ClouDr Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1647.100/-288.166
=-5.72

ClouDr Group's current Enterprise Value is HK$1,647 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ClouDr Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-288 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ClouDr Group  (HKSE:09955) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ClouDr Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.31/-0.656
=At Loss

ClouDr Group's share price for today is HK$3.31.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ClouDr Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.656.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ClouDr Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ClouDr Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ClouDr Group (HKSE:09955) Business Description

Traded in Other Exchanges
Address
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

ClouDr Group (HKSE:09955) Headlines

No Headlines